133 related articles for article (PubMed ID: 16849574)
1. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
Rooney RJ
Cell Growth Differ; 2001 Oct; 12(10):505-16. PubMed ID: 11682462
[TBL] [Abstract][Full Text] [Related]
3. TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.
Hu X; Cui D; Moscinski LC; Zhang X; Maccachero V; Zuckerman KS
Cytokine; 2007 Feb; 37(2):155-62. PubMed ID: 17459720
[TBL] [Abstract][Full Text] [Related]
4. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
5. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.
Dagon Y; Dovrat S; Vilchik S; Hacohen D; Shlomo G; Sredni B; Salzberg S; Nir U
Oncogene; 2001 Dec; 20(56):8045-56. PubMed ID: 11781817
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
7. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
Whang YM; Park KH; Jung HY; Jo UH; Kim YH
Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
[TBL] [Abstract][Full Text] [Related]
8. Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells.
Barrett KL; Demiranda D; Katula KS
Cell Biol Int; 2002; 26(1):19-28. PubMed ID: 11779217
[TBL] [Abstract][Full Text] [Related]
9. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells.
Dan S; Yamori T
Biochem Biophys Res Commun; 2001 Jan; 280(3):861-7. PubMed ID: 11162602
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation.
Julian LM; Palander O; Seifried LA; Foster JE; Dick FA
Oncogene; 2008 Mar; 27(11):1572-9. PubMed ID: 17891180
[TBL] [Abstract][Full Text] [Related]
11. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
Nomura N; Nomura M; Newcomb EW; Zagzag D
Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
[TBL] [Abstract][Full Text] [Related]
12. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
[TBL] [Abstract][Full Text] [Related]
13. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
[TBL] [Abstract][Full Text] [Related]
14. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9.
Cai D; Byth KF; Shapiro GI
Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259
[TBL] [Abstract][Full Text] [Related]
15. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells.
Barascu A; Besson P; Le Floch O; Bougnoux P; Jourdan ML
Int J Biochem Cell Biol; 2006 Feb; 38(2):196-208. PubMed ID: 16194618
[TBL] [Abstract][Full Text] [Related]
16. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells.
Yuan J; Yan R; Krämer A; Eckerdt F; Roller M; Kaufmann M; Strebhardt K
Oncogene; 2004 Jul; 23(34):5843-52. PubMed ID: 15208674
[TBL] [Abstract][Full Text] [Related]
17. Discovery and evaluation of dual CDK1 and CDK2 inhibitors.
Payton M; Chung G; Yakowec P; Wong A; Powers D; Xiong L; Zhang N; Leal J; Bush TL; Santora V; Askew B; Tasker A; Radinsky R; Kendall R; Coats S
Cancer Res; 2006 Apr; 66(8):4299-308. PubMed ID: 16618755
[TBL] [Abstract][Full Text] [Related]
18. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection.
Cho NH; Kang S; Hong S; An HJ; Choi YH; Jeong GB; Choi HK
Cancer Lett; 2006 Feb; 232(2):170-8. PubMed ID: 16458113
[TBL] [Abstract][Full Text] [Related]
19. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
Pang LP; Huang W; Sun Q; Guo W; Li RT; Cui JR
Anticancer Drugs; 2008 Feb; 19(2):167-74. PubMed ID: 18176113
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
Xu Z; Choudhary S; Voznesensky O; Mehrotra M; Woodard M; Hansen M; Herschman H; Pilbeam C
Cancer Res; 2006 Jul; 66(13):6657-64. PubMed ID: 16818639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
